UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
BDRX holding history
Biodexa Pharmaceuticals Plc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BDRX overviewAll 13F holders of BDRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 25
- Value
- $73
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 25 | $73 | <0.1% | −0−1.6% | ReducedConverted for a 1-for-5 split | Holders |
| Q1 2026 | 127 | $78 | <0.1% | −1,973−94.0% | Reduced | Holders |
| Q4 2025 | 2,100 | $4.77K | <0.1% | −4,825−69.7% | Reduced | Holders |
| Q3 2025 | 6,925 | $46.1K | <0.1% | +4,936+248.2% | Added | Holders |
| Q2 2025 | 1,989 | $1.72K | <0.1% | −16,843−89.4% | Reduced | Holders |
| Q1 2025 | 18,832 | $24.9K | <0.1% | +11,785+167.2% | Added | Holders |
| Q4 2024 | 7,047 | $28.5K | <0.1% | −248,399−97.2% | Reduced | Holders |
| Q3 2024 | 255,446 | $72.0K | <0.1% | +245,449+2,455.2% | Added | Holders |
| Q2 2024 | 9,997 | $8.96K | <0.1% | +7,559+310.0% | Added | Holders |
| Q1 2024 | 2,438 | $3.95K | <0.1% | +1,838+306.3% | Added | Holders |
| Q4 2023 | 600 | $1.61K | <0.1% | +529+745.1% | Added | Holders |
| Q3 2023 | 71 | $354 | <0.1% | −142,137−100.0% | Reduced | Holders |
| Q2 2023 | 142,208 | $9.81K | <0.1% | +142,208 | New | Holders |